{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:18:24Z","timestamp":1784132304327,"version":"3.55.0"},"reference-count":210,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Retinoblastoma is an early-childhood retinal malignancy driven predominantly by biallelic RB1 inactivation and consequent RB\u2013E2F checkpoint deregulation. Post-translational modifications (PTMs) add a rapid, reversible regulatory layer that rewires RB-centered signaling, chromatin control, metabolic adaptation, and therapy resistance. This review summarizes PTM mechanisms relevant to retinoblastoma, highlighting phosphorylation- and ubiquitination-centric circuits, as well as acetylation and methylation that modulate RB pathway function and downstream oncogenic phenotypes. We discuss actionable therapeutic opportunities, including compounds and degraders targeting PTM enzymes, and emphasize underexplored modifications such as SUMOylation, lactylation, and glycosylation that warrant systematic investigation in retinoblastoma. Finally, we integrate PTM biology with emerging immunotherapies and propose rational PTM\u2013immunotherapy combinations and biomarker-guided translation to improve durable eye salvage and metastatic control.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1820785","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:55:47Z","timestamp":1778651747000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Lifei","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Tongde Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongde Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongde Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongde Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nursing, Tongde Hospital of Zhejiang Province","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000542193","article-title":"Worldwide burden of retinoblastoma from 1990 to 2021","volume":"67","author":"Feng","year":"2024","journal-title":"Ophthalmic Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-011-9505-3","article-title":"RB1 mutations and second primary Malignancies after hereditary retinoblastoma","volume":"11","author":"Dommering","year":"2012","journal-title":"Fam Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2025.12.21","article-title":"Retinoblastoma management in China: clinical challenges","volume":"18","author":"Wang","year":"2025","journal-title":"Int J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00250-9","article-title":"The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries","volume":"10","year":"2022","journal-title":"Lancet Glob Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/IIO.0000000000000587","article-title":"Angiogenesis signaling in retinoblastoma: prognostic and therapeutic applications","volume":"65","author":"Yang","year":"2025","journal-title":"Int Ophthalmol Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2015.06.012","article-title":"The biology of retinoblastoma","volume":"134","author":"Mendoza","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100058","article-title":"Recent progress in retinoblastoma: pathogenesis, presentation, diagnosis and management","volume":"13","author":"Zhou","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/1566524020666210104113003","article-title":"The role of retinoblastoma protein in cell cycle regulation: an updated review","volume":"21","author":"Roufayel","year":"2021","journal-title":"Curr Mol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature13813","article-title":"Rb suppresses human cone-precursor-derived retinoblastoma tumours","volume":"514","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.3390\/ijms26178675","article-title":"Human retinal organoid modeling defines developmental window and therapeutic vulnerabilities in MYCN-amplified retinoblastoma","volume":"26","author":"Park","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2174\/156800907782418266","article-title":"Targeting MDM2 and MDMX in retinoblastoma","volume":"7","author":"Laurie","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"B12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semcancer.2024.05.001","article-title":"p53\/MDM2 signaling pathway in aging, senescence and tumorigenesis","volume":"101","author":"Huang","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00863-0","article-title":"Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour","volume":"47","author":"Zhang","year":"2024","journal-title":"Cell Oncol (Dordr)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2025.0074","article-title":"UBE2C, regulated by n6-methyladenosine methyltransferase METTL3, is an oncogene in retinoblastoma via PI3K-AKT pathway","volume":"44","author":"Chen","year":"2025","journal-title":"DNA Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2025.195106","article-title":"A putative PIWIL\/piRNA-OTX2 network: an emerging model for epigenetic regulation of cancer stemness in retinoblastoma","volume":"1868","author":"Roy","year":"2025","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12142","article-title":"Targeting Notch signaling as a novel therapy for retinoblastoma","volume":"7","author":"Asnaghi","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6701","article-title":"Blockade of sonic hedgehog signaling decreases viability and induces apoptosis in retinoblastoma cells: the key role of the PI3K\/Akt pathway","volume":"14","author":"Song","year":"2017","journal-title":"Oncol Lett"},{"key":"B18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/cimb47100844","article-title":"Epigenetic factors in pathogenesis of retinoblastoma: DNA methylation and histone acetylation","volume":"47","author":"Kiosis","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2025.02.011","article-title":"The role of protein lactylation: a kaleidoscopic post-translational modification in cancer","volume":"85","author":"Iozzo","year":"2025","journal-title":"Mol Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108749","article-title":"Exploring the landscape of post-translational modification in drug discovery","volume":"265","author":"Cao","year":"2025","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/biology14101370","article-title":"The role of protein arginine methylation as a post-translational modification in cellular homeostasis and disease","volume":"14","author":"Li","year":"2025","journal-title":"Biol (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41419-025-07832-5","article-title":"Post-translational modification of transcription factors: perspectives in vascular medicine","volume":"16","author":"Astanina","year":"2025","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41420-025-02535-4","article-title":"Acyl post-translational modification of proteins by metabolites in cancer cells","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20220251","article-title":"A global view of the human post-translational modification landscape","volume":"480","author":"Kitamura","year":"2023","journal-title":"Biochem J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating tumor suppressor genes: post-translational modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-022-00818-x","article-title":"Post-translational modifications on the retinoblastoma protein","volume":"29","author":"Zhou","year":"2022","journal-title":"J BioMed Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1010","article-title":"Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma","volume":"6","author":"Ewens","year":"2017","journal-title":"Cancer Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2024.08.004","article-title":"The expanding landscape of canonical and non-canonical protein phosphorylation","volume":"49","author":"Houles","year":"2024","journal-title":"Trends Biochem Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"Chapter 14:Unit 14 1","DOI":"10.1002\/0471143030.cb1401s00","article-title":"Overview of protein phosphorylation","author":"Sefton","year":"2001","journal-title":"Curr Protoc Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90517-5","article-title":"Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation","volume":"58","author":"Chen","year":"1989","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.2588006","article-title":"Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product","volume":"246","author":"Mihara","year":"1989","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0092-8674(92)90249-c","article-title":"Regulation of retinoblastoma protein functions by ectopic expression of human cyclins","volume":"70","author":"Hinds","year":"1992","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90251-9","article-title":"Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation","volume":"62","author":"Laiho","year":"1990","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3179","article-title":"OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways","volume":"47","author":"Li","year":"2015","journal-title":"Int J Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3892\/or.2023.8583","article-title":"Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice","volume":"50","author":"Kim","year":"2023","journal-title":"Oncol Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"12621","DOI":"10.3390\/ijms232012621","article-title":"ADAM10 and ADAM17-novel players in retinoblastoma carcinogenesis","volume":"23","author":"Van Meenen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2019.12.47","article-title":"Long noncoding RNA UCA1 facilitates cell proliferation and inhibits apoptosis in retinoblastoma by activating the PI3K\/Akt pathway","volume":"9","author":"Yuan","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5114\/pjp.2024.142177","article-title":"ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p\/TSC1\/ULK signaling","volume":"75","author":"Yang","year":"2024","journal-title":"Pol J Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1038\/s41598-023-49994-2","article-title":"miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK\/MAPK\/ERK signaling","volume":"14","author":"Gao","year":"2024","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12906-017-2023-6","article-title":"Antitumor effect of quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3464","article-title":"C-MET-dependent signal transduction mediates retinoblastoma growth by regulating PKM2 nuclear translocation","volume":"38","author":"Dai","year":"2020","journal-title":"Cell Biochem Funct"},{"key":"B42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/08977194.2010.518616","article-title":"Second AKT: the rise of SGK in cancer signalling","volume":"28","author":"Bruhn","year":"2010","journal-title":"Growth Factors"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/2270097","article-title":"Tumor suppressor role of INPP4B in chemoresistant retinoblastoma","volume":"2023","author":"Miroschnikov","year":"2023","journal-title":"J Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.3390\/ijms25084572","article-title":"Role of protein tyrosine phosphatase receptor type E (PTPRE) in chemoresistant retinoblastoma","volume":"25","author":"Mohren","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1007\/s12672-025-02229-4","article-title":"AMPK: an enzyme that may be effective in cancer and metabolic diseases","volume":"16","author":"Guney Kalkan","year":"2025","journal-title":"Discov Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.06.049","article-title":"The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt\/AMPK\/mTOR inhibition","volume":"504","author":"Ke","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-021-09915-2","article-title":"Pre-clinical evidence that salinomycin is active against retinoblastoma via inducing mitochondrial dysfunction, oxidative damage and AMPK activation","volume":"53","author":"Li","year":"2021","journal-title":"J Bioenerg Biomembr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2023.07.001","article-title":"Depleted hexokinase1 and lack of AMPKalpha activation favor OXPHOS-dependent energetics in retinoblastoma tumors","volume":"261","author":"Babu","year":"2023","journal-title":"Transl Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189461","article-title":"STAT3 axis in cancer and cancer stem cells: from oncogenesis to targeted therapies","volume":"1880","author":"Godugu","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110636","article-title":"Therapeutic targeting of ITGA1 delayed retinoblastoma progression through suppression of STAT3 signaling","volume":"260","author":"Gu","year":"2025","journal-title":"Exp Eye Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2022.1610273","article-title":"RING-finger protein 6 promotes drug resistance in retinoblastoma via JAK2\/STAT3 signaling pathway","volume":"28","author":"Chai","year":"2022","journal-title":"Pathol Oncol Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23501","article-title":"MiR-452-5p facilitates retinoblastoma cell growth and invasion via the SOCS3\/JAK2\/STAT3 pathway","volume":"37","author":"Wu","year":"2023","journal-title":"J Biochem Mol Toxicol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26521","article-title":"Long non-coding RNA H19 suppresses retinoblastoma progression via counteracting miR-17\u201392 cluster","volume":"119","author":"Zhang","year":"2018","journal-title":"J Cell Biochem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107256","article-title":"Receptor-activated transcription factors and beyond: multiple modes of Smad2\/3-dependent transmission of TGF-beta signaling","volume":"300","author":"Miyazawa","year":"2024","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0543-2","article-title":"ACVR1C\/SMAD2 signaling promotes invasion and growth in retinoblastoma","volume":"38","author":"Asnaghi","year":"2019","journal-title":"Oncogene"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112087","article-title":"The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p\/SMAD2 axis","volume":"393","author":"Han","year":"2020","journal-title":"Exp Cell Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1909962","article-title":"Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p\/SMAD2 axis in retinoblastoma","volume":"12","author":"Yin","year":"2021","journal-title":"Bioengineered"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2021.2007535","article-title":"Circ_0000527 drives retinoblastoma progression by regulating miR-1236-3p\/SMAD2 pathway","volume":"47","author":"Liang","year":"2022","journal-title":"Curr Eye Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40478-019-0785-4","article-title":"Downregulation of Nodal inhibits metastatic progression in retinoblastoma","volume":"7","author":"Asnaghi","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70044","article-title":"Ubiquitination in cancer: mechanisms and therapeutic opportunities","volume":"45","author":"Zhu","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","article-title":"The role of ubiquitination in tumorigenesis and targeted drug discovery","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3700","article-title":"Roles of F-box proteins in cancer","volume":"14","author":"Wang","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.10.3","article-title":"Ubiquitination-related miRNA-mRNA interaction is a potential mechanism in the progression of retinoblastoma","volume":"62","author":"Chen","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-3663","article-title":"p27 as a transcriptional regulator: new roles in development and cancer","volume":"80","author":"Razavipour","year":"2020","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.17.3.465","article-title":"Expression of cdc2 and p27(KIP1) phosphorylation in mitotic cells of the human retinoblastoma","volume":"17","author":"Kase","year":"2006","journal-title":"Int J Mol Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.16.2.257","article-title":"Phosphorylation of p27(KIP1) in the developing retina and retinoblastoma","volume":"16","author":"Kase","year":"2005","journal-title":"Int J Mol Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122409","article-title":"Skp2: a critical molecule for ubiquitination and its role in cancer","volume":"338","author":"Feng","year":"2024","journal-title":"Life Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29177","article-title":"SKP2, positively regulated by circ_ODC1\/miR-422a axis, promotes the proliferation of retinoblastoma","volume":"121","author":"Du","year":"2020","journal-title":"J Cell Biochem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/ng.498","article-title":"Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+\/- mice","volume":"42","author":"Wang","year":"2010","journal-title":"Nat Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s0959-437x(02)00010-2","article-title":"The VHL tumor suppressor gene: insights into oxygen sensing and cancer","volume":"128","author":"Kaelin","year":"2017","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.10.9","article-title":"microRNA-222-mediated VHL downregulation facilitates retinoblastoma chemoresistance by increasing HIF1alpha expression","volume":"61","author":"Li","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01642","article-title":"MDM2 degrader as a promising therapeutic strategy for cancer treatment","volume":"68","author":"Wu","year":"2025","journal-title":"J Med Chem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.350","article-title":"MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation","volume":"36","author":"Qi","year":"2017","journal-title":"Oncogene"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2023.1610801","article-title":"MDM2 promotes cancer cell survival through regulating the expression of HIF-1alpha and pVHL in retinoblastoma","volume":"29","author":"Zhang","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12957-025-04139-9","article-title":"FOXO1 phosphorylation as a context-dependent molecular switch in cancer: from mechanisms to precision therapy","volume":"24","author":"Wang","year":"2025","journal-title":"World J Surg Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2010.510943","article-title":"Camptothecin induces apoptosis of human retinoblastoma cells via activation of FOXO1","volume":"36","author":"Han","year":"2011","journal-title":"Curr Eye Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109389","article-title":"The role of EZH2 as a potential therapeutic target in retinoblastoma","volume":"227","author":"Zhao","year":"2023","journal-title":"Exp Eye Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/genes13020266","article-title":"CRL4(Cdt2) ubiquitin ligase, a genome caretaker controlled by Cdt2 binding to PCNA and DNA","volume":"13","author":"Mazian","year":"2022","journal-title":"Genes (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001738","article-title":"Denticleless homolog-mediated ubiquitin-proteasome degradation of forkhead box O1 contributes to development of carboplatin resistance in retinoblastoma","volume":"36","author":"Liu","year":"2025","journal-title":"Anticancer Drugs"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1186\/s12967-025-07333-1","article-title":"Targeted protein degradation of Wnt\/beta-catenin signaling pathway: an effective strategy for cancer therapy","volume":"23","author":"Mao","year":"2025","journal-title":"J Transl Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2478\/aite-2024-0020","article-title":"S-adenosylmethionine inhibits the proliferation of retinoblastoma cell Y79, induces apoptosis and cell cycle arrest of Y79 cells by inhibiting the Wnt2\/beta-catenin pathway","volume":"72","author":"Liu","year":"2024","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109340","article-title":"LncRNA MEG3 attenuates the Malignancy of retinoblastoma cells through inactivating PI3K \/Akt\/mTOR signaling pathway","volume":"226","author":"Yan","year":"2023","journal-title":"Exp Eye Res"},{"key":"B83","article-title":"LncRNA MEG3 inhibits retinoblastoma invasion and metastasis by inducing beta-catenin degradation","volume":"12","author":"Gao","year":"2022","journal-title":"Am J Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.70069","article-title":"SIRT1 in aging and diseases","volume":"126","author":"Abdulkhaliq","year":"2025","journal-title":"J Cell Biochem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/biology14111510","article-title":"The roles of Sirt1 in breast and gynecologic Malignancies","volume":"14","author":"Ding","year":"2025","journal-title":"Biol (Basel)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"BSR20201626","DOI":"10.1042\/BSR20201626","article-title":"KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1\/JNK signaling pathway by targeting miR-124\/SP1 axis","volume":"41","author":"Zhang","year":"2021","journal-title":"Biosci Rep"},{"key":"B87","article-title":"USP22 down-regulation facilitates human retinoblastoma cell aging and apoptosis via inhibiting TERT\/P53 pathway","volume":"21","author":"Zhou","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.781247","article-title":"P38 mitogen-activated protein kinase protects against retinoblastoma through regulating USP22\/SIRT1\/SOST axis","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/15384101.2021.1874685","article-title":"microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1","volume":"20","author":"Rong","year":"2021","journal-title":"Cell Cycle"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1970305","article-title":"Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1\/PI3K\/AKT pathway in retinoblastoma","volume":"20","author":"Wang","year":"2021","journal-title":"Cell Cycle"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.788587","article-title":"The roles of EphB2 in cancer","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2037659","article-title":"LINC00488 induces tumorigenicity in retinoblastoma by regulating microRNA-30a-5p\/EPHB2 axis","volume":"31","author":"Cui","year":"2023","journal-title":"Ocul Immunol Inflammation"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-025-05357-3","article-title":"USP33 facilitates retinoblastoma growth by deubiquitinating and stabilizing EPHB2 protein","volume":"197","author":"Zhang","year":"2025","journal-title":"Appl Biochem Biotechnol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41419-022-04675-2","article-title":"Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000439594","article-title":"Sirtuin1 expression and correlation with histopathological features in retinoblastoma","volume":"2","author":"Batra","year":"2015","journal-title":"Ocul Oncol Pathol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12902","article-title":"IGF2BP3-dependent N6-methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1","volume":"40","author":"Li","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.01.013","article-title":"Acetylation: a new target for protein degradation in cancer","volume":"11","author":"Crawford","year":"2025","journal-title":"Trends Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-91459-1_13","article-title":"Reversible acetylation of non-histone proteins in human cancers","volume":"75","author":"Feng","year":"2025","journal-title":"Results Probl Cell Differ"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070151","article-title":"Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1","volume":"407","author":"Wong","year":"2007","journal-title":"Biochem J"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.137612","article-title":"Methylation of the retinoblastoma tumor suppressor by SMYD2","volume":"285","author":"Saddic","year":"2010","journal-title":"J Biol Chem"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600176","article-title":"Acetylation regulates the differentiation-specific functions of the retinoblastoma protein","volume":"23","author":"Nguyen","year":"2004","journal-title":"EMBO J"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400591","article-title":"DNA-damage-responsive acetylation of pRb regulates binding to E2F-1","volume":"7","author":"Markham","year":"2006","journal-title":"EMBO Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.068924","article-title":"Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation","volume":"123","author":"Pickard","year":"2010","journal-title":"J Cell Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2014.10.021","article-title":"The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb","volume":"426","author":"Jansma","year":"2014","journal-title":"J Mol Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/35083062","article-title":"Acetylation control of the retinoblastoma tumour-suppressor protein","volume":"3","author":"Chan","year":"2001","journal-title":"Nat Cell Biol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.3.856-865.2002","article-title":"Retinoblastoma protein transcriptional repression through histone deacetylation of a single nucleosome","volume":"22","author":"Morrison","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1235","article-title":"Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin","volume":"7","author":"Gonzalo","year":"2005","journal-title":"Nat Cell Biol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/35404","article-title":"Retinoblastoma protein recruits histone deacetylase to repress transcription","volume":"391","author":"Brehm","year":"1998","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/35410","article-title":"Retinoblastoma protein represses transcription by recruiting a histone deacetylase","volume":"391","author":"Magnaghi-Jaulin","year":"1998","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.3390\/ijms25136910","article-title":"Histone deacetylases in retinoblastoma","volume":"25","author":"Lisek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.03.129","article-title":"Downregulation of HDAC9 inhibits cell proliferation and tumor formation by inducing cell cycle arrest in retinoblastoma","volume":"473","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6405","article-title":"MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9","volume":"16","author":"Jin","year":"2018","journal-title":"Exp Ther Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0424","article-title":"Inhibiting p53 acetylation reduces cancer chemotoxicity","volume":"77","author":"Zheng","year":"2017","journal-title":"Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.stem.2015.08.004","article-title":"HDAC8 inhibition specifically targets Inv(16) acute myeloid leukemic stem cells by restoring p53 acetylation","volume":"17","author":"Qi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B115","article-title":"Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1","volume":"33","author":"Drago-Ferrante","year":"2008","journal-title":"Int J Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000728","article-title":"Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation","volume":"37","author":"Kawano","year":"2010","journal-title":"Int J Oncol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41417-020-0181-z","article-title":"LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway","volume":"28","author":"Gao","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200705051","article-title":"Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit","volume":"179","author":"Blais","year":"2007","journal-title":"J Cell Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nature09343","article-title":"NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein","volume":"466","author":"Tooley","year":"2010","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.311","article-title":"Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein","volume":"30","author":"Carr","year":"2011","journal-title":"EMBO J"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00945-14","article-title":"PRMT4-mediated arginine methylation negatively regulates retinoblastoma tumor suppressor protein and promotes E2F-1 dissociation","volume":"35","author":"Kim","year":"2015","journal-title":"Mol Cell Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.135","article-title":"Tudor-domain protein PHF20L1 reads lysine methylated retinoblastoma tumour suppressor protein","volume":"24","author":"Carr","year":"2017","journal-title":"Cell Death Differ"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403737111","article-title":"Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor","volume":"111","author":"Carr","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.6","article-title":"JMJD3 promotes SAHF formation in senescent WI38 cells by triggering an interplay between demethylation and phosphorylation of RB protein","volume":"22","author":"Zhao","year":"2015","journal-title":"Cell Death Differ"},{"key":"B125","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/biom8010011","article-title":"DOT1L and H3K79 methylation in transcription and genomic stability","volume":"8","author":"Wood","year":"2018","journal-title":"Biomolecules"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.4161\/cc.28104","article-title":"The histone methyltransferase Dot1\/DOT1L as a critical regulator of the cell cycle","volume":"13","author":"Kim","year":"2014","journal-title":"Cell Cycle"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2025.075","article-title":"DOT1L as a therapeutic target: Insights into epigenetic regulation and cancer treatment","volume":"33","author":"Choi","year":"2025","journal-title":"Biomol Ther (Seoul)"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41419-021-04431-y","article-title":"Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy","volume":"12","author":"Mao","year":"2021","journal-title":"Cell Death Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2011.09.001","article-title":"Versatility of PRMT5-induced methylation in growth control and development","volume":"36","author":"Karkhanis","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118754","article-title":"Targeting PRMT5 in cancer: Mechanistic insights and clinical progress","volume":"193","author":"Lee","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218075","article-title":"Cracking PRMT5: Mechanistic insights, clinical advances, and AI-driven strategies","volume":"634","author":"Alipourgivi","year":"2025","journal-title":"Cancer Lett"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108286","article-title":"EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma","volume":"202","author":"Liu","year":"2021","journal-title":"Exp Eye Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-022-00807-0","article-title":"PRMT5 promotes retinoblastoma development","volume":"36","author":"Jiang","year":"2023","journal-title":"Hum Cell"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115332","article-title":"Mechanistic insights into SUMOylation and its role in cancer pathogenesis: bridging oncogenesis, immunity, and therapeutic opportunities","volume":"164","author":"Qu","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"56096","DOI":"10.3791\/56096","article-title":"In vivo detection and analysis of Rb protein SUMOylation in human cells","author":"Meng","year":"2017","journal-title":"J Vis Exp"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208539","article-title":"Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor","volume":"24","author":"Ledl","year":"2005","journal-title":"Oncogene"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2016.1182267","article-title":"SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase","volume":"15","author":"Meng","year":"2016","journal-title":"Cell Cycle"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.177","article-title":"SENP1-modulated sumoylation regulates retinoblastoma protein (RB) and Lamin A\/C interaction and stabilization","volume":"35","author":"Sharma","year":"2016","journal-title":"Oncogene"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15223","article-title":"SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma","volume":"113","author":"Meng","year":"2022","journal-title":"Cancer Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00876-7","article-title":"Biochemistry and regulation of histone lysine L-lactylation","volume":"27","author":"Sheng","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.62347\/QRTR7828","article-title":"Decoding protein lactylation in the pathogenesis and progression of gynecological cancer","volume":"15","author":"Fang","year":"2025","journal-title":"Am J Cancer Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07992-y","article-title":"AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases","volume":"634","author":"Li","year":"2024","journal-title":"Nature"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217804","article-title":"Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications","volume":"625","author":"Yang","year":"2025","journal-title":"Cancer Lett"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-024-00725-x","article-title":"Genetics of glycosylation in mammalian development and disease","volume":"25","author":"Stanley","year":"2024","journal-title":"Nat Rev Genet"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/164_2025_751","article-title":"Glycosylation in cancer","volume":"288","author":"Duarte","year":"2025","journal-title":"Handb Exp Pharmacol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.07.013","article-title":"Targeting glycosylation to enhance tumor immunotherapy","volume":"46","author":"Zhu","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3892\/or.14.1.291","article-title":"Comparative genomics on Fgf11 orthologs","volume":"14","author":"Katoh","year":"2005","journal-title":"Oncol Rep"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300789200","article-title":"YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation)","volume":"278","author":"Hiromura","year":"2003","journal-title":"J Biol Chem"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2016.1167297","article-title":"Reduced O-GlcNAcase expression promotes mitotic errors and spindle defects","volume":"15","author":"Lanza","year":"2016","journal-title":"Cell Cycle"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.677534","article-title":"E2F1 transcription factor regulates O-linked N-acetylglucosamine (O-GlcNAc) transferase and O-GlcNAcase expression","volume":"290","author":"Muthusamy","year":"2015","journal-title":"J Biol Chem"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-328x(94)90372-7","article-title":"Identification and characterization of the human cell adhesion molecule contactin","volume":"21","author":"Reid","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.6.2865","article-title":"Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain","volume":"168","author":"Juang","year":"2002","journal-title":"J Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"27309","DOI":"10.1038\/s41598-024-76135-0","article-title":"Auxiliary effect of trolox on coenzyme Q(10) restricts angiogenesis and proliferation of retinoblastoma cells via the ERK\/Akt pathway","volume":"14","author":"Upreti","year":"2024","journal-title":"Sci Rep"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-3157-1","article-title":"Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition","volume":"253","author":"Zheng","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.09.144","article-title":"Galangin inhibits the cell progression and induces cell apoptosis through activating PTEN and Caspase-3 pathways in retinoblastoma","volume":"97","author":"Zou","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B158","doi-asserted-by":"publisher","first-page":"899","DOI":"10.17219\/acem\/70418","article-title":"Inhibition of migration and invasion by berberine via inactivation of PI3K\/Akt and p38 in human retinoblastoma cell line","volume":"27","author":"Wang","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-00387","article-title":"Sinomenine can inhibit the growth and invasion ability of retinoblastoma cell through regulating PI3K\/AKT signaling pathway","volume":"43","author":"Zheng","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-200050","article-title":"TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT\/mTOR signaling pathway","volume":"31","author":"Bao","year":"2021","journal-title":"Cancer biomark"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1515\/med-2021-0343","article-title":"miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1","volume":"16","author":"Zhang","year":"2021","journal-title":"Open Med (Wars)"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/ijms130910736","article-title":"Combined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells","volume":"13","author":"Song","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2676","article-title":"Curcumin exerts antitumor effects in retinoblastoma cells by regulating the JNK and p38 MAPK pathways","volume":"38","author":"Yu","year":"2016","journal-title":"Int J Mol Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16970","article-title":"Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K\/mTOR inhibitor NVP-BEZ235","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11487","article-title":"Pentoxifylline enhances the apoptotic effect of carboplatin in Y79 retinoblastoma cells","volume":"33","author":"Cruz-Galvez","year":"2019","journal-title":"In Vivo"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109367","article-title":"Tubeimoside II inhibits TGF-beta1-induced metastatic progression of human retinoblastoma cells through suppressing redoxosome-dependent EGFR activation","volume":"335","author":"Chen","year":"2021","journal-title":"Chem Biol Interact"},{"key":"B167","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1124\/molpharm.120.000231","article-title":"Antitumor activity of novel signal transducer and activator of transcription 3 inhibitors on retinoblastoma","volume":"100","author":"Jo","year":"2021","journal-title":"Mol Pharmacol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2025.2564068","article-title":"From serendipity to strategy: molecular glue degraders in cancer therapeutics","volume":"60","author":"Darling","year":"2025","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191772","article-title":"Molecular glue degrader function of SPOP inhibitors enhances STING-dependent immunotherapy efficacy in melanoma models","volume":"135","author":"Zhu","year":"2025","journal-title":"J Clin Invest"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03241-8","article-title":"Discovery of a molecular glue for EGFR degradation","volume":"44","author":"Wang","year":"2025","journal-title":"Oncogene"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.7150\/thno.59020","article-title":"A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity","volume":"11","author":"Yan","year":"2021","journal-title":"Theranostics"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34559","article-title":"GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent","volume":"153","author":"Dalpatraj","year":"2023","journal-title":"Int J Cancer"},{"key":"B173","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12032-025-03185-3","article-title":"Anti-tumor effects and mechanism of the histone demethylase inhibitor GSK-J4 in non-small cell lung cancer cells","volume":"43","author":"Xu","year":"2025","journal-title":"Med Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3511","article-title":"Oncogenic KRAS sensitizes lung adenocarcinoma to GSK-J4-induced metabolic and oxidative stress","volume":"79","author":"Hong","year":"2019","journal-title":"Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206798","article-title":"Donafenib and GSK-J4 synergistically induce ferroptosis in liver cancer by upregulating HMOX1 expression","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.2.34","article-title":"Antitumoral potential of the histone demethylase inhibitor GSK-J4 in retinoblastoma","volume":"65","author":"Zhang","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B177","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12094-025-03995-x","article-title":"Clinical progress and functional modalities of HDAC inhibitor-based combination therapies in cancer treatment","volume":"28","author":"Talom","year":"2026","journal-title":"Clin Transl Oncol"},{"key":"B178","article-title":"MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors","volume":"62","author":"Jaboin","year":"2002","journal-title":"Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-004-0122-7","article-title":"Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells","volume":"48","author":"Karasawa","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2019.10.30","article-title":"HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin","volume":"8","author":"Sun","year":"2019","journal-title":"Transl Cancer Res"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113801","article-title":"Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection","volume":"156","author":"Dey","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B182","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ijms21010234","article-title":"2-Deoxy-d-glucose and its analogs: From diagnostic to therapeutic agents","volume":"21","author":"Pajak","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S29688","article-title":"Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors","volume":"6","author":"Pina","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-5033","article-title":"Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma","volume":"51","author":"Pina","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B185","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12885-026-15546-w","article-title":"NAT10 promotes the glycolysis of retinoblastoma through ac4C modification of PFKFB3 mRNA","volume":"26","author":"Li","year":"2026","journal-title":"BMC Cancer"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013699","article-title":"Antiangiogenic activity of 2-deoxy-D-glucose","volume":"5","author":"Merchan","year":"2010","journal-title":"PloS One"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.822330","article-title":"Treatment of retinoblastoma: What is the latest and what is the future","volume":"12","author":"Schaiquevich","year":"2022","journal-title":"Front Oncol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.949193","article-title":"Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1499700","article-title":"Prospects of anti-GD2 immunotherapy for retinoblastoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-013-1448-7","article-title":"Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis","volume":"139","author":"Liu","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2315","article-title":"Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells","volume":"29","author":"Wang","year":"2013","journal-title":"Oncol Rep"},{"key":"B192","first-page":"290","article-title":"EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy","volume":"18","author":"Mitra","year":"2012","journal-title":"Mol Vis"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2584-x","article-title":"SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma","volume":"144","author":"Chen","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"10185","DOI":"10.1038\/s41598-020-67101-7","article-title":"Clinical relevance of B7H3 expression in retinoblastoma","volume":"10","author":"Ganesan","year":"2020","journal-title":"Sci Rep"},{"key":"B195","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1038\/s41598-025-34331-6","article-title":"B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma","volume":"16","author":"Sujjitjoon","year":"2026","journal-title":"Sci Rep"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02529-4","article-title":"Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma","volume":"69","author":"Singh","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.864473","article-title":"Comprehensive analysis of the immune cell infiltration landscape and immune-related methylation in retinoblastoma","volume":"13","author":"Mao","year":"2022","journal-title":"Front Genet"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2081379","article-title":"Multimodal imaging and photothermal synergistic immunotherapy of retinoblastoma with tuftsin-loaded carbonized MOF nanoparticles","volume":"29","author":"Zou","year":"2022","journal-title":"Drug Delivery"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25631","article-title":"A phase I study of the anti-idiotype vaccine Racotumomab in neuroblastoma and other pediatric refractory Malignancies","volume":"62","author":"Cacciavillano","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B200","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1186\/s12885-019-6131-1","article-title":"CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing","volume":"19","author":"Andersch","year":"2019","journal-title":"BMC Cancer"},{"key":"B201","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00262-023-03587-0","article-title":"Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3","volume":"73","author":"Eichholz","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2625","article-title":"BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers","volume":"12","author":"Coussy","year":"2020","journal-title":"Sci Transl Med"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.06.014","article-title":"Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells","volume":"137","author":"Xie","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1242","article-title":"Integrative multiomic profiling of triple-negative breast cancer for identifying suitable therapies","volume":"30","author":"Jovanovic","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B205","doi-asserted-by":"publisher","first-page":"e165268","DOI":"10.1172\/jci.insight.165268","article-title":"Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS\/STING pathway","volume":"8","author":"Dong","year":"2023","journal-title":"JCI Insight"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216605","article-title":"AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy","volume":"583","author":"Sun","year":"2024","journal-title":"Cancer Lett"},{"key":"B207","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1038\/s41467-021-27620-x","article-title":"Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response","volume":"12","author":"Yen","year":"2021","journal-title":"Nat Commun"},{"key":"B208","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","article-title":"Phosphorylated RB promotes cancer immunity by inhibiting NF-kappaB activation and PD-L1 expression","volume":"73","author":"Jin","year":"2019","journal-title":"Mol Cell"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.01.023","article-title":"Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation","volume":"189","author":"Zuo","year":"2026","journal-title":"Cell"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.01.043","article-title":"Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response","volume":"188","author":"He","year":"2025","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1820785\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:55:49Z","timestamp":1778651749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1820785\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":210,"alternative-id":["10.3389\/fimmu.2026.1820785"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1820785","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1820785"}}